整合表观基因组以识别肝细胞癌的驱动因素
该研究对正常、肝硬化和肝细胞癌(HCC)肝组织进行全基因组5mC、5hmC、四种组蛋白修饰及转录水平评估,整合生物信息学分析揭示HCC进展中表观基因组扰动特征,并鉴定出COMT和FMO3两个表观遗传驱动位点。
要点
- HCC肝组织呈现5hmC深度丢失及位点特异性5mC和5hmC获得。
- 增强子重塑是HCC表观基因组改变的突出特征。
- 整合表观遗传参数可识别HCC驱动位点如COMT和FMO3。
核心结论
- 整合多种表观遗传参数是识别HCC表观遗传驱动因素及阐明表观基因组失调如何促进肝病和HCC的有力工具。
研究设计与样本
- 对正常、肝硬化和HCC肝组织进行全基因组5mC、5hmC、四种组蛋白修饰(H3K4me1、H3K27ac、H3K4me3、H3K27me3)及转录水平评估。
主要发现
- HCC中表观遗传调节因子显著失调,表观基因组以5hmC深度丢失、位点特异性5mC和5hmC获得及组蛋白修饰谱显著改变为标志。
- 数据整合显示这些标记协同影响HCC增殖相关基因的转录,例如HCC中获得的活跃增强子区高5hmC与表达升高相关。
- 通过整合方法鉴定的COMT和FMO3位点在肝源性癌细胞系中异位重新表达后增加凋亡并降低细胞活力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Disruption of epigenetic mechanisms has been intimately linked to the etiology of human cancer. Understanding how these epigenetic mechanisms (including DNA methylation [5mC], hydroxymethylation [5hmC], and histone post-translational modifications) work in concert to drive cancer initiation and progression remains unknown. Hepatocellular carcinoma (HCC) is increasing in frequency in Western countries but lacks efficacious treatments. The epigenome of HCC remains understudied. To better understand the epigenetic underpinnings of HCC, we performed a genome-wide assessment of 5mC, 5hmC, four histone modifications linked to promoter/enhancer function (H3K4me1, H3K27ac, H3K4me3, and H3K27me3), and transcription across normal, cirrhotic, and HCC liver tissue. Implementation of bioinformatic strategies integrated these epigenetic marks with each other and with transcription to provide a comprehensive epigenetic profile of how and when the liver epigenome is perturbed during progression to HCC. Our data demonstrate significant deregulation of epigenetic regulators combined with disruptions in the epigenome hallmarked by profound loss of 5hmC, locus-specific gains in 5mC and 5hmC, and markedly altered histone modification profiles, particularly remodeling of enhancers. Data integration demonstrates that these marks collaborate to influence transcription (e.g., hyper-5hmC in HCC-gained active enhancers is linked to elevated expression) of genes regulating HCC proliferation. Two such putative epigenetic driver loci identified through our integrative approach, COMT and FMO3, increase apoptosis and decrease cell viability in liver-derived cancer cell lines when ectopically re-expressed. Conclusion: Altogether, integration of multiple epigenetic parameters is a powerful tool for identifying epigenetically regulated drivers of HCC and elucidating how epigenome deregulation contributes to liver disease and HCC.
引用
- Hlady RA, Sathyanarayan A, Thompson JJ, et al. Integrating the Epigenome to Identify Drivers of Hepatocellular Carcinoma. Hepatology. 2019. PMID: 30136421. doi:10.1002/hep.30211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。